Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

British Journal of Pharmacology

Volumn 158, Issue 1, 2009, Pages 87-103

  Mitchell, Jd ^a   Maguire, Jj ^a   Davenport, Ap ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Energy homeostasis; Neuromedin S; Neuromedin U; NMU 1; NMU 2; Smooth muscle contraction

Indexed keywords

FM 3; FM 4; G PROTEIN COUPLED RECEPTOR; GPR 66; MESSENGER RNA; NEUROMEDIN S; NEUROMEDIN U; NEUROPEPTIDE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; BLADDER CARCINOMA; BONE REMODELING; BRAIN; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CIRCADIAN RHYTHM; ENERGY BALANCE; GASTROINTESTINAL TRACT; HUMAN; KNOCKOUT MOUSE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; NOCICEPTION; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SEPTIC SHOCK; SPECIES COMPARISON; SPINAL CORD; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; ENERGY METABOLISM; HUMANS; LIGANDS; METABOLIC SYNDROME X; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH; NEUROPEPTIDES; VASOCONSTRICTION;

EID: 69249230893     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00252.x     Document Type: Review

References (145)

1. 1 and NMU2 receptors stably expressed in clonal human embryonic kidney-293 cells. Pharmacology 72 : 33 41.
2. Albrecht U, Sun ZS, Eichele G, Lee CC (1997). A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 91 : 1055 1064.
3. Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M et al. (2001). Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 20 : 6196 6204.
4. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153 (Suppl. 2 S1 S209.
5. Augood SJ, Keast JR, Emson PC (1988). Distribution and characterization of neuromedin-U-like immunoreactivity in rat brain and intestine and in guinea-pig intestine. Regul Pept 20 : 281 292.
6. Austin C, Lo G, Nandha KA, Meleagros L, Bloom SR (1995). Cloning and Characterization of the cDNA encoding the human neuromedin U (NMU) precursor - NMU expression in the human gastrointestinal tract. J Mol Endocrinol 14 : 157 169.
7. Ballesta J, Carlei F, Bishop AE, Steel JH, Gibson SJ, Fahey M et al. (1988). Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal-tract and brain of the rat. Neuroscience 25 : 797 816.
8. Banks WA, Tschop M, Robinson SM, Heiman ML (2002). Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302 : 822 827.
9. Benito-Orfila MA, Domin J, Nandha KA, Bloom SR (1991). The motor effect of neuromedin-U on rat stomach in vitro. Eur J Pharmacol 193 : 329 333.
10. Bhattacharyya S, Luan J, Farooqi IS, Keogh J, Montague C, Brennand J et al. (2004). Studies of the neuromedin U-2 receptor gene in human obesity: evidence for the existence of two ancestral forms of the receptor. J Endocrinol 183 : 115 120.
11. Bockman CS, Abel PW, Hicks JW, Conlon JM (1989). Evidence that neuromedin-U may regulate gut motility in reptiles but not in mammals. Eur J Pharmacol 171 : 255 257.
12. Bornstein SR (1997). Is leptin a stress related peptide? Nat Med 3 : 937 937.
13. Brighton PJ, Szekeres PG, Willars GB (2004a). Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol Rev 56 : 231 248.
14. Brighton PJ, Szekeres PG, Wise A, Willars GB (2004b). Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to G alpha(q/11) and G alpha(i) and an irreversible ligand-receptor interaction. Mol Pharmacol 66 : 1544 1556.
15. Brighton PJ, Wise A, Dass NB, Willars GB (2008). Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissue. J Pharmacol Exp Ther 325 : 154 164.
16. Brown DR, Quito FL (1988). Neuromedin-U octapeptide alters ion-transport in porcine jejunum. Eur J Pharmacol 155 : 159 162.
17. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P (1995). Recombinant mouse Ob protein - evidence for a peripheral signal linking adiposity and central neural networks. Science 269 : 546 549.
18. Cao CQ, Yu XH, Dray A, Filosa A, Perkins MN (2003). A pro-nociceptive role of neuromedin U in adult mice. Pain 104 : 609 616.
19. Chen TB, Zhou M, Walker B, Harriot P, Mori K, Miyazato M et al. (2006). Structural and functional analogs of the novel mammalian neuropeptide, neuromedin S (NmS), in the dermal venoms of Eurasian bombinid toads. Biochem Biophys Res Commun 345 : 377 384.
20. Chu CP, Jin QH, Kunitake T, Kato K, Nabekura T, Nakazato M et al. (2002). Cardiovascular actions of central neuromedin U in conscious rats. Regul Pept 105 : 29 34.
21. Dass NB, Bassil AK, North-Laidler VJ, Morrow R, Aziz E, Tuladhar BR et al. (2007). Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU receptor activation. Br J Pharmacol 150 : 502 508.
22. Dogrukol-Ak D, Tore F, Tuncel N (2004). Passage of VIP/PACAP/secretin family across the blood-brain barrier: therapeutic effects. Curr Pharm Des 10 : 1325 1340.
23. Domin J, Ghatei MA, Chohan P, Bloom SR (1986). Characterization of neuromedin-U like immunoreactivity in rat, guinea-pig and human tissue extracts using a specific radioimmunoassay. Biochem Biophys Res Commun 140 : 1127 1134.
24. Domin J, Ghatei MA, Chohan P, Bloom SR (1987). Neuromedin-U - a study of its distribution in the rat. Peptides 8 : 779 784.
25. Domin J, Yiangou Y, Spokes RA, Aitken A, Parmar KB, Chrysanthou BJ et al. (1989). The distribution, purification and pharmacological action of an amphibian neuromedin-U. J Biol Chem 264 : 20881 20885.
26. Domin J, Benito-Orfila MA, Nandha KA, Aitken A, Bloom SR (1992). The purification and sequence-analysis of an avian neuromedin-U. Regul Pept 41 : 1 8.
27. Doyle MW, Bailey TW, Jin YH, Appleyard SM, Low MJ, Andresen MC (2004). Strategies for cellular identification in nucleus tractus solitarius slices. J Neurosci Methods 137 : 37 48.
28. Euer NI, Kaul S, Deissler H, Mobus VJ, Zeillinger R, Weidle UH (2005). Identification of L1CAM, Jagged2 and neuromedin U as ovarian cancer-associated antigens. Oncol Rep 13 : 375 387.
29. Fang LY, Zhang MC, Li CX, Dong SZ, Hu YH (2006). Chemical genetic analysis reveals the effects of NMU2R on the expression of peptide hormones. Neurosci Lett 404 : 148 153.
30. Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Habata Y, Hinuma S et al. (2000). Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J Biol Chem 275 : 21068 21074.
31. Fukue Y, Sato T, Teranishi H, Hanada R, Takahashi T, Nakashima Y et al. (2006). Regulation of gonadotropin secretion and puberty onset by neuromedin U. FEBS Lett 580 : 3485 3488.
32. Funes S, Hedrick JA, Yang SJ, Shan LX, Bayne M, Monsma FJ et al. (2002). Cloning and characterization of murine neuromedin U receptors. Peptides 23 : 1607 1615.
33. Furness JB, Pompolo S, Murphy R, Giraud A (1989). Projections of neurons with neuromedin U-like immunoreactivity in the small-intestine of the guinea-pig. Cell Tissue Res 257 : 415 422.
34. Gardiner SM, Compton AM, Bennett T, Domin J, Bloom SR (1990). Regional hemodynamic effects of neuromedin-U in conscious rats. Am J Physiol 258 : R32 R38.
35. Garlton J, Szekeres P, Pullen M, Sarau HM, Aiyar N, Shabon U et al. (2004). Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology (Berl) 177 : 1 14.
36. Graham ES, Turnbull Y, Fotheringham P, Nilaweera K, Mercer JG, Morgan PJ et al. (2003). Neuromedin U and neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status. J Neurochem 87 : 1165 1173.
37. Graham ES, Littlewood P, Turnbull Y, Mercer JG, Morgan PJ, Barrett P (2005). Neuromedin-U is regulated by the circadian clock in the SCN of the mouse. Eur J Neurosci 21 : 814 819.
38. Guan XM, Yu H, Jiang Q, Van Der Ploeg LH, Liu Q (2001). Distribution of neuromedin U receptor subtype 2 mRNA in the rat brain. Brain Res Gene Expr Patterns 1 : 1 4.
39. Hainerova I, Torekov SS, Ek J, Finkova M, Borch-Johnsen K, Jorgensen T et al. (2006). Association between neuromedin U gene variants and overweight and obesity. J Clin Endocrinol Metab 91 : 5057 5063.
40. Hanada R, Nakazato M, Murakami N, Sakihara S, Yoshimatsu H, Toshinai K et al. (2001). A role for neuromedin U in stress response. Biochem Biophys Res Commun 289 : 225 228.
41. Hanada R, Teranishi H, Pearson JT, Kurokawa M, Hosoda H, Fukushima N et al. (2004). Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med 10 : 1067 1073.
42. Hanada T, Date Y, Shimbara T, Sakihara S, Murakami N, Hayashi Y et al. (2003). Central actions of neuromedin U via corticotropin-releasing hormone. Biochem Biophys Res Commun 311 : 954 958.
43. Hashimoto T, Masui H, Uchida Y, Sakura N, Okimura K (1991). Agonistic and antagonistic activities of neuromedin-U-8 analogs substituted with glycine or D-amino-acid on contractile activity of chicken crop smooth-muscle preparations. Chem Pharm Bull (Tokyo) 39 : 2319 2322.
44. Hay DL, Poyner DR, Sexton PM (2006). GPCR modulation by RAMPS. Pharmacol Ther 109 : 173 197.
45. Hedrick JA, Morse K, Shan LX, Qiao XD, Pang L, Wang S et al. (2000). Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol Pharmacol 58 : 870 875.
46. Hoebel BG (1965). Hypothalamic lesions by electrocauterization: disinhibition of feeding and self-stimulation. Science 149 : 452 453.
47. Honzawa M, Sudoh T, Minamino N, Tohyama M, Matsuo H (1987). Topographic localization of neuromedin U-like structures in the rat-brain - an immunohistochemical study. Neuroscience 23 : 1103 1122.
48. Honzawa M, Sudoh T, Minamino N, Kangawa K, Matsuo H (1990). Neuromedin-U-like immunoreactivity in rat intestine - regional distribution and immunohistochemical study. Neuropeptides 15 : 1 9.
49. Hosoya M, Moriya T, Kawamata Y, Ohkubo S, Fujii R, Matsui H et al. (2000). Identification and functional characterization of a novel subtype of neuromedin U receptor. J Biol Chem 275 : 29528 29532.
50. Howard AD, Wang RP, Pong SS, Mellin TN, Strack A, Guan XM et al. (2000). Identification of reeptors for neuromedin U and its role in feeding. Nature 406 : 70 74.
51. Hsu SH, Luo CW (2007). Molecular dissection of G protein preference using G(s)alpha chimeras reveals novel ligand signaling of GPCRs. Am J Physiol Endocrinol Metab 293 : E1021 E1029.
52. Ida T, Mori K, Miyazato M, Egi Y, Abe S, Nakahara K et al. (2005). Neuromedin S is a novel anorexigenic hormone. Endocrinology 146 : 4217 4223.
53. Ivanov TR, Lawrence CB, Stanley PJ, Luckman SM (2002). Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143 : 3813 3821.
54. Ivanov TR, Le Rouzic P, Stanley PJ, Ling WY, Parello R, Luckman SM (2004). Neuromedin U neurones in the rat nucleus of the tractus solitarius are catecholaminergic and respond to peripheral cholecystokinin. J Neuroendocrinol 16 : 612 619.
55. Iwai T, Iinuma Y, Kodani R, Oka JI (2008). Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents. Neurosci Res 61 : 113 119.
56. Jaszberenyi M, Bagasi Z, Thurzo B, Foldesi I, Telegdy G (2007). Endocrine and behavioral effects of neuromedin S. Horm Behav 52 : 631 639.
57. Jethwa PH, Small CJ, Smith KL, Seth A, Darch SJ, Abbott CR et al. (2005). Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. Am J Physiol Endocrinol Metab 289 : E301 E305.
58. Jethwa PH, Smith KL, Small CJ, Abbott CR, Darch SJ, Murphy KG et al. (2006). Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. Endocrinology 147 : 2886 2892.
59. Johnson EN, Appelbaum ER, Carptenter DC, Cox RF, Disa J, Foley JJ et al. (2004). Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1. J Immunol 173 : 7230 7238.
60. Jones NA, Morton MF, Prendergast CE, Powell GL, Shankley NP, Hollingsworth SJ (2006). Neuromedin U stimulates contraction of human long saphenous vein and gastrointestinal smooth muscle in vitro. Regul Pept 136 : 109 116.
61. Kaczmarek P, Malendowicz LK, Pruszynska-Oszmalek E, Wojciechowicz T, Szczepankiewicz D, Szkudelski T et al. (2006). Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets. Int J Mol Med 18 : 951 955.
62. Kage R, O'Harte F, Thim L, Conlon JM (1991). Rabbit neuromedin U-25 - lack of conservation of a posttranslational processing site. Regul Pept 33 : 191 198.
63. Kamisoyama H, Honda K, Saneyasu T, Sugahara K, Hasegawa S (2007). Central administration of neuromedin U suppresses food intake in chicks. Neurosci Lett 420 : 1 5. (Pubitemid 46777097)
64. Kojima M, Haruno R, Nakazato M, Date Y, Murakami N, Hanada R et al. (2000). Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem Biophys Res Commun 276 : 435 438.
65. Kowalski TJ, Spar BD, Markowitz L, Maguire M, Golovko A, Yang S et al. (2005). Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. J Endocrinol 185 : 151 164.
66. Krahn DD, Gosnell BA, Majchrzak MJ (1990). The anorectic effects of CRH and restraints decrease with repeated exposures. Biol Psychiatry 27 : 1094 1102.
67. Kuroda K, Nakashima J, Kanao K, Kikuchi E, Miyajima A, Horiguchi Y et al. (2007). Interleukin 6 is associated with cachexia in patients with prostate cancer. Urology 69 : 113 117.
68. Leak RK, Moore RY (2001). Topographic organization of suprachiasmatic nucleus projection neurons. J Comp Neurol 433 : 312 334.
69. Lee WH, Liu SB, Shen JH, Jin Y, Lai R, Zhang Y (2005). Identification and molecular cloning of a novel neuromedin U analog from the skin secretions of toad Bombina maxima. Regul Pept 129 : 43 47.
70. Light AR, Willcockson HH (1999). Spinal laminae I-II neurons in rat recorded in vivo in whole cell, tight seal configuration: properties and opioid responses. J Neurophysiol 82 : 3316 3326.
71. Maggi CA, Patacchini R, Giuliani S, Turini D, Barbanti G, Rovero P et al. (1990). Motor response of the human isolated small-intestine and urinary bladder to porcine neuromedin U-8. Br J Pharmacol 99 : 186 188.
72. Malendowicz LK, Andreis PG, Markowska A, Nowak M, Warchol JB, Neri G et al. (1994a). Effects of neuromedin U-8 on the secretory activity of the rat adrenal cortex - evidence for an indirect action requiring the presence of the zona medullaris. Res Exp Med (Berl) 194 : 69 79.
73. Malendowicz LK, Nussdorfer GG, Markowska A, Tortorella C, Nowak M, Warchol JB (1994b). Effects of neuromedin-U (NMU)-8 on the rat hypothalamo-pituitary-adrenal axis - evidence of a direct effect of NMU-8 on the adrenal gland. Neuropeptides 26 : 47 53.
74. Malendowicz LM, Nussdorfer GG, Nowak KW, Mazzocchi G (1993). Effects of neuromedin U-8 on the rat pituitary-adrenocortical axis. In Vivo (Athens) 7 : 419 422.
75. Mangold C, Ksiazek I, Yun SW, Berger E, Binkert C (2008). Distribution of neuromedin U binding sites in the rat CNS revealed by in vitro receptor autoradiography. Neuropeptides 42 : 377 386.
76. Maruyama K, Konno N, Ishiguro K, Wakasugi T, Uchiyama M, Shioda S et al. (2008). Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity. J Neuroendocrinol 20 : 71 78.
77. Melcher C, Bader R, Walther S, Simakov O, Pankratz MJ (2006). Neuromedin U and its putative Drosophila homolog hugin. PLoS Biol 4 : 316 316.
78. Meng T, Su HR, Binkert C, Fischli W, Zhou L, Shen JK et al. (2008). Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay. Acta Pharmacol Sin 29 : 517 527.
79. Michel C, Dunn-Meynell A, Levin BE (2004). Reduced brain CRH and GR mRNA expression precedes obesity in juvenile rats bred for diet-induced obesity. Behav Brain Res 154 : 511 517.
80. Minamino N, Kangawa K, Matsuo H (1985). Neuromedin-U-8 and neuromedin-U-25 - novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem Biophys Res Commun 130 : 1078 1085.
81. Minamino N, Kangawa K, Honzawa M, Matsuo H (1988). Isolation and structural determination of rat neuromedin-U. Biochem Biophys Res Commun 156 : 355 360.
82. Mitchell JD, Maguire JJ, Kuc RE, Davenport AP (2009). Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 & S in the human cardiovascular system. Cardiovasc Res 81 : 353 361.
83. Mondal MS, Date Y, Murakami N, Toshinai K, Shimbara T, Kangawa K et al. (2003). Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system. Am J Physiol Gastrointest Liver Physiol 284 : G963 G969.
84. Mori K, Miyazato M, Ida T, Murakami N, Serino R, Ueta Y et al. (2005). Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J 24 : 325 335.
85. Moriyama M, Furue H, Katafuchi T, Teranishi H, Sato T, Kano T et al. (2004). Presynaptic modulation by neuromedin U of sensory synaptic transmission in rat spinal dorsal horn neurones. J Physiol - London 559 : 707 713.
86. Moriyama M, Sato T, Inoue H, Fukuyama S, Teranishi H, Kangawa K et al. (2005). The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells. J Exp Med 202 : 217 224.
87. Moriyama M, Matsukawa A, Kudoh S, Takahashi T, Sato T, Kano T et al. (2006a). The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock. Biochem Biophys Res Commun 341 : 1149 1154.
88. Moriyama M, Fukuyama S, Inoue H, Matsumoto T, Sato T, Tanaka K et al. (2006b). The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. Am J Physiol Lung Cell Mol Physiol 290 : L971 L977.
89. Morley JE, Levine AS (1982). Corticotropin releasing-factor, grooming and ingestive behavior. Life Sci 31 : 1459 1464.
90. Murphy R, Turner CA, Furness JB, Parker L, Giraud A (1990). Isolation and microsequence analysis of a novel form of neuromedin-U from guinea-pig small-intestine. Peptides 11 : 613 617.
91. Nakahara K, Kojima M, Hanada R, Egi Y, Ida T, Miyazato M et al. (2004a). Neuromedin U is involved in nociceptive reflexes and adaptation to environmental stimuli in mice. Biochem Biophys Res Commun 323 : 615 620.
92. Nakahara K, Hanada R, Murakami N, Teranishi H, Ohgusu H, Fukushima N et al. (2004b). The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system. Biochem Biophys Res Commun 318 : 156 161.
93. Nakazato M, Hanada R, Murakami N, Date Y, Mondal MS, Kojima M et al. (2000). Central effects of neuromedin U in the regulation of energy homeostasis. Biochem Biophys Res Commun 277 : 191 194.
94. Nandha KA, Benitoorfila MA, Smith DM, Bloom SR (1993). Characterization of the rat uterine neuromedin-U receptor. Endocrinology 133 : 482 486.
95. Nandha KA, Benito-Orfila MA, Jamal H, Akinsanya KO, Bloom SR, Smith DM (1999). Effect of steroids and the estrous cycle on uterine neuromedin U receptor expression. Peptides 20 : 1203 1209.
96. Niimi M, Murao K, Taminato T (2001). Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem. Endocrine 16 : 201 206.
97. Nogueiras R, Tovar S, Mitchell SE, Barrett P, Rayner DV, Dieguez C et al. (2006). Negative energy balance and leptin regulate neuromedin-U expression in the rat pars tuberalis. J Endocrinol 190 : 545 553.
98. Novak CM, Zhang M, Levine JA (2006). Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis. J Neuroendocrinol 18 : 594 601.
99. Novak CM, Zhang M, Levine JA (2007). Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity. Brain Res 1169 : 57 68.
100. O'Harte F, Bockman CS, Abel PW, Conlon JM (1991a). Isolation, structural characterization and pharmacological activity of dog neuromedin-U. Peptides 12 : 11 15.
101. O'Harte F, Bockman CS, Zeng WY, Abel PW, Harvey S, Conlon JM (1991b). Primary structure and pharmacological activity of a nonapeptide related to neuromedin-U isolated from chicken intestine. Peptides 12 : 809 812.
102. Okimura K, Sakura N, Ohta S, Kurosawa K, Hashimoto T (1992). Contractile activity of porcine neuromedin U-25 and various neuromedin U-related peptide-fragments on isolated chicken crop smooth muscle. Chem Pharm Bull (Tokyo) 40 : 1500 1503.
103. Ozaki Y, Onaka T, Nakazato M, Saito J, Kanemoto K, Matsumoto T et al. (2002). Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology 143 : 4320 4329.
104. Park Y, Kim YJ, Adams ME (2002). Identification of G protein-coupled receptors for Drosophila PRXamide peptides, CCAP, corazonin, and AKH supports a theory of ligand-receptor coevolution. Proc Natl Acad Sci USA 99 : 11423 11428.
105. 1 receptor knockout mice. Br J Pharmacol 147 : 886 896.
106. Quan H, Funabashi T, Furuta M, Kimura F (2003). Effects of neuromedin U on the pulsatile LH secretion in ovariectomized rats in association with feeding conditions. Biochem Biophys Res Commun 311 : 721 727.
107. Quan H, Funabashi T, Kimura F (2004). Intracerebroventricular injection of corticotropin-releasing hormone receptor antagonist blocks the suppression of pulsatile luteinizing hormone secretion induced by neuromedin U in ovariectomized rats after 48 hours of fasting. Neurosci Lett 369 : 33 38.
108. Raddatz R, Wilson AE, Artymyshyn R, Bonini JA, Borowsky B, Boteju LW et al. (2000). Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J Biol Chem 275 : 32452 32459.
109. Rucinski M, Ziolkowska A, Neri G, Trejter M, Zemleduch T, Tyczewska M et al. (2007). Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat. Int J Mol Med 20 : 255 259.
110. Rucinski M, Ziolkowska A, Tyczewska M, Szyszka M, Malendowicz LK (2008). Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform. International. J Mol Med 22 : 363 368.
111. Sakamoto T, Mori K, Nakahara K, Miyazato M, Kangawa K, Sameshima H et al. (2007). Neuromedin S exerts an antidiuretic action in rats. Biochem Biophys Res Commun 361 : 457 461.
112. Sakamoto T, Mori K, Miyazato M, Kangawa K, Sameshima H, Nakahara K et al. (2008). Involvement of neuromedin S in the oxytocin release response to suckling stimulus. Biochem Biophys Res Commun 375 : 49 53.
113. Sakura N, Ohta S, Uchida Y, Kurosawa K, Okimura K, Hashimoto T (1991). Structure-activity-relationships of rat neuromedin-U for smooth muscle contraction. Chem Pharm Bull (Tokyo) 39 : 2016 2020.
114. Sakura N, Kurosawa K, Hashimoto T (1995). Structure-activity- relationships of neuromedin-U.1. Contractile activity of dog neuromedin-U-related peptides on isolated chicken crop smooth muscle. Chem Pharm Bull (Tokyo) 43 : 1148 1153.
115. Salmon AL, Johnsen AH, Bienert M, McMurray G, Nandha KA, Bloom SR et al. (2000). Isolation, structural characterization, and bioactivity of a novel neuromedin U analog from the defensive skin secretion of the Australasian tree frog, Litoria caerulea. J Biol Chem 275 : 4549 4554.
116. Sasaki T, Shimizu T, Wakiguchi H, Yokotani K (2008). Centrally administered neuromedin U elevates plasma adrenaline by brain prostanoid TP receptor-mediated mechanisms in rats. Eur J Pharmacol 592 : 81 86.
117. Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M et al. (2007). Central control of bone remodeling by neuromedin U. Nat Med 13 : 1234 1240.
118. Shan LX, Qiao XD, Crona JH, Behan J, Wang S, Laz T et al. (2000). Identification of a novel neuromedin U receptor subtype expressed in the central nervous system. J Biol Chem 275 : 39482 39486.
119. Shetzline SE, Rallapalli R, Dowd KJ, Zou SM, Nakata Y, Swider CR et al. (2004). Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. Blood 104 : 1833 1840.
120. Shimizu F, Matsuzaki T, Iwasa T, Minakuchi M, Kuwahara A, Yasui T et al. (2008). Estradiol suppresses NMU mRNA expression during sexual maturation in the female rat pituitary. Int J Dev Neurosci 26 : 381 384.
121. Shousha S, Nakahara K, Miyazato M, Kangawa K, Murakami N (2005). Endogenous neuromedin U has anorectic effects in the Japanese quail. Gen Comp Endocrinol 140 : 156 163.
122. Shousha S, Nakahara K, Sato M, Mori K, Miyazato M, Kangawa K et al. (2006). Effect of neuromedin S on feeding regulation in the Japanese quail. Neurosci Lett 391 : 87 90.
123. Shukla AK, Haase W, Reinhart C, Michel H (2007). Heterologous expression and comparative characterization of the human neuromedin U subtype II receptor using the methylotrophic yeast Pichia pastoris and mammalian cells. Int J Biochem Cell Biol 39 : 931 942. (Pubitemid 46575324)
124. Strassmann G, Fong M, Kenney JS, Jacob CO (1992). Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J Clin Invest 89 : 1681 1684.
125. Sumi S, Inoue K, Kogire M, Doi R, Takaori K, Suzuki T et al. (1987). Effect of synthetic neuromedin U-8 and U-25, novel peptides identified in porcine spinal-cord, on splanchnic circulation in dogs. Life Sci 41 : 1585 1590.
126. Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, Smith A et al. (2000). Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J Biol Chem 275 : 20247 20250.
127. Takahashi K, Furukawa C, Takano A, Ishikawa N, Kato T, Hayama S et al. (2006). The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res 66 : 9408 9419.
128. Tan CP, McKee KK, Liu QY, Palyha OC, Feighner SD, Hreniuk DL et al. (1998). Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. Genomics 52 : 223 229.
129. Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM, Frierson HF (2004). Reduced expression of metastasis suppressor RhoGD12 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 10 : 3800 3806.
130. Thompson EL, Murphy KG, Todd JF, Martin NM, Small CJ, Ghatei MA et al. (2004). Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. Biochem Biophys Res Commun 323 : 65 71.
131. Torres R, Croll SD, Vercollone J, Reinhardt J, Griffiths J, Zabski S et al. (2007). Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses. Pain 130 : 267 278.
132. Trejter M, Neri G, Rucinski M, Majchrzak M, Nussdorfer GG, Malendowicz LK (2008). Neuromedin-U stimulates enucleation-induced adrenocortical regeneration in the rat. Int J Mol Med 21 : 683 687.
133. Tsubota Y, Kakimoto N, Owada-Makabe K, Yukawa K, Liang XM, Mune M et al. (2003). Hypotensive effects of neuromedin U microinjected into the cardiovascular-related region of the rat nucleus tractus solitarius. Neuroreport 14 : 2387 2390.
134. Vigo E, Roa J, Pineda R, Castellano JM, Navarro VM, Aguilar E et al. (2007a). Novel role of the anorexigenic peptide neuromedin U in the control of LH secretion and its regulation by gonadal hormones and photoperiod. Am J Physiol Endocrinol Metab 293 : E1265 E1273.
135. Vigo E, Roa J, Lopez M, Castellano JM, Fernandez-Fernandez R, Navarro VM et al. (2007b). Neuromedin S as novel putative regulator of luteinizing hormone secretion. Endocrinology 148 : 813 823.
136. Westfall TD, McCafferty GP, Pullen M, Gruver S, Sulpizio AC, Aiyar VN et al. (2002). Characterization of neuromedin U effects in canine smooth muscle. J Pharmacol Exp Ther 301 : 987 992.
137. Wren AM, Small CJ, Abbott CR, Jethwa PH, Kennedy AR, Murphy KG et al. (2002). Hypothalamic actions of neuromedin U. Endocrinology 143 : 4227 4234.
138. Wu Y, McRoberts K, Berr SS, Frierson HF, Conaway M, Theodorescu D (2007). Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene 26 : 765 773.
139. Xia H, Liu L, Reinhart C, Michel H (2008). Heterologous expression of human Neuromedin U receptor 1 and its subsequent solubilization and purification. Biochim Biophys Acta 1778 : 2203 2209.
140. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M et al. (2002). Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2 : 485 495. (Pubitemid 41043953)
141. Yokota M, Ozaki Y, Sakamoto F, Yamada S, Saito J, Fujihara H et al. (2004). Fos expression in CRF-containing neurons in the rat paraventricular nucleus after central administration of neuromedin U. Stress 7 : 109 112.
142. Yu XH, Cao CQ, Mennicken F, Puma C, Dray A, O'Donnell D et al. (2003). Pro-nociceptive effects of neuromedin U in rat. Neuroscience 120 : 467 474.
143. Zeng HK, Gragerov A, Hohmann JG, Pavlova MN, Schimpf BA, Xu H et al. (2006). Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding. Mol Cell Biol 26 : 9352 9363.
144. Zheng X, Hu YH, Liu JH, Ouyang KQ (2005). Screening of active compounds as neuromedin U2 receptor agonist from natural products. Bioorg Med Chem Lett 15 : 4531 4535.
145. Ziolkowska A, Macchi C, Trejter M, Rucinski M, Nowak M, Nussdorfer GG et al. (2008). Effects of neuromedin-U on immature rat adrenocortical cells: in vitro and in vivo studies. Int J Mol Med 21 : 303 307.